Eurolyser Diagnostics - Premium Laboratory Equipment

PSA (prostate specific antigen): Elevate prostatic diseases with Eurolyser’s new assay

Tuesday, 4. December 2018

Eurolyser presents a new parameter for the measurement of PSA (prostate specific antigen). This test provides reliable, precise and immediate results.

The parameter

Prostate specific antigen (PSA) is a glycoprotein with a molecular weight of 34,000 which is located in the prostatic organization and seminal plasma. The PSA out of the blood increases with the occurence of prostate cancer, prostatomegaly, prostatitis and other prostatic diseases. Particularly blood PSA levels increase remarkably in patients with prostate cancer.

Applications in diagnostics

Eurolyser’s PSA test kit was specifically designed for physicians, who need to assess their patients’ risk for prostatic diseases.

Your advantages

  • In-house/on-site diagnosis (no more time delay due to sent out samples)
  • Results in less than 6 minutes (from serum)
  • Excellent accuracy
  • Easy test procedure


Antibodyadsorbed latex particles and PSA in the sample react immunologically, and causing the latex particles to agglutinate. This agglutination results in a change of turbidity, and the change in absorbance is a measure of the amount of PSA in the sample.

Measurement range:

Serum/plasma:            2 – 50 ng/ml
EDTA whole blood:      3 – 50 ng/ml

For more information, please visit the PSA test kit page

Eurolyser News

7. February 2019

Sysmex Corporation, Japan and EUROLYSER, Austria to expand their co-operation in the Japan...
»

4. December 2018

PSA (prostate specific antigen): Elevate prostatic diseases with Eurolyser’s new ass...
»

21. November 2018

K+ Potassium: A new veterinary test for heart and lung muscle function assessment...
»

26. September 2018

Bovine Progesterone: We expand our veterinary reproduction diagnostic test range...
»